The Dallas Cowboys got contributions up and down the roster in their 31-28 win over the Kansas City Chiefs on Thanksgiving. Their stars were the biggest catalysts, but Sam Williams, Malik Davis, Reddy ...

In the span of a week, federal investigators in Colorado announced the largest fentanyl seizure and the largest methamphetamine seizure ever recorded in the state — both tied to suspected cartel ...

Share on Pinterest The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy New guidelines from the World Health Organization (WHO) ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in ...

People who stopped taking weight-loss drugs before or during pregnancy were associated with greater gestational weight gain and had a higher risk of preterm delivery and gestational diabetes compared ...

The booming market for weight-loss drugs has propelled Eli Lilly LLY1.16%increase; green up pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...

WASHINGTON — Pentagon chief Pete Hegseth said Tuesday that he only learned of a second strike on an alleged Venezuelan drug boat to finish off two survivors “a couple of hours later.” Hegseth ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...